Journals / Türk Osteoporoz Dergisi / 2018 / Cilt: 24 - Sayı: 2

The Relationship Between Interleukin-17 and Osteoporosis in Patients with Rheumatoid Arthritis

Romatoid Artrit Tanılı Hastalarda İnterlökin-17 ile Osteoporoz Arasındaki İlişki

Pages
46–52
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

While there is no relationship between IL-17 and disease activity and functional status in RA; IL-17 levels are high in RA patients with OP.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study; it is aimed to compare interleukin-17 (IL-17) levels in rheumatoid arthritis (RA) and osteoporosis (OP) patients compared to healthy controls, and to determine the relationship between IL-17 and disease activity, functional status and presence of OP in RA.Materials and Methods: Eighty five patients were classified in four groups.
📊
Key Findings & Data:Group 1: RA + OP (n=21), group 2: RA (n=22), group 3: 20 healthy volunteers, and group 4: OP (n=22).
💡
Conclusion & Impact:While there is no relationship between IL-17 and disease activity and functional status in RA; IL-17 levels are high in RA patients with OP.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study; it is aimed to compare interleukin-17 (IL-17) levels in rheumatoid arthritis (RA) and osteoporosis (OP) patients compared to healthy controls, and to determine the relationship between IL-17 and disease activity, functional status and presence of OP in RA.Materials and Methods: Eighty five patients were classified in four groups. Group 1: RA + OP (n=21), group 2: RA (n=22), group 3: 20 healthy volunteers, and group 4: OP (n=22). Demographical data, bone densitometry values, serum 25-hydroxy vitamin D and IL-17 levels were recorded. The disease duration, medications, pain levels of the patients and the disease activities were noted, and the disease activities of patients were evaluated by the health assessment questionnaire.Results: No difference was detected between IL-17 levels of patients with and without RA (p>0.05). Likewise, we could not establish a relationship between disease activity and IL-17 levels. However, IL-17 levels of RA patients with OP were significantly higher when compared with patients without OP. Rheumatoid factor and IL-17 levels were higher for RA patients with OP. While a significant, negative correlation was established between IL-17 and lumbar T-score with femoral bone mineral density, no correlation was detected between other variables in RA patients.Conclusion: IL-17 levels are elevated in RA and OP. While there is no relationship between IL-17 and disease activity and functional status in RA; IL-17 levels are high in RA patients with OP.

Özet

Amaç: Bu çalışmada; romatoid artrit (RA) ve osteoporoz (OP) hastalarında interlökin (IL)-17 düzeylerinin sağlıklı kontrollere göre karşılaştırılması ve RA da hastalık aktivitesi, fonksiyonel durum ve OP varlığının IL-17 ile arasındaki ilişkisinin belirlenmesi amaçlanmıştır. Gereç ve Yöntem: Seksen beş hasta 4 grupta sınıflandırıldı. Grup 1: RA + OP (n=21), grup 2: RA (n=22), grup 3: 20 sağlıklı gönüllü, grup 4: OP (n=22). Demografik veriler, kemik dansitometresi değerleri, serum 25-hidroksi vitamin D ve IL-17 düzeyleri kaydedildi. Hastaların hastalık süreleri, ilaçları, ağrı düzeyleri ve hastalık aktiviteleri de kaydedildi ve hastalık aktiviteleri sağlık değerlendirme anketi ile değerlendirildi. Bulgular: RA olan ve olmayan hastaların IL-17 düzeyleri arasında fark saptanmadı (p>0,05). Benzer şekilde, hastalık aktivitesi ile IL-17 düzeyleri arasında bir ilişki saptamadık. Bununla birlikte, OP’si olmayan hastalarla karşılaştırıldığında, OP’li RA hastalarının IL-17 düzeyleri anlamlı olarak yüksek bulundu. OP’li RA hastalarında romatoid faktör ve IL-17 düzeyleri daha yüksekti. IL-17 ve lumbar T skoru ile femoral kemik mineral yoğunluğu arasında anlamlı, negatif korelasyon saptanırken, RA hastalarında diğer değişkenler arasında korelasyon saptanmadı. Sonuç: RA ve OP’de IL-17 seviyeleri yüksektir. RA’da IL-17 ile hastalık aktivitesi ve fonksiyonel durum arasında ilişki saptanmaz iken, OP’si olan RA’lı hastalarda IL-17 düzeyleri yüksektir.

🔖

Cite This Article

TÜRE, M., YEŞİL, H., AKDENİZ, S., AKDENİZ, O., SAKALLI, N., GÜRER, G. (2022). The Relationship Between Interleukin-17 and Osteoporosis in Patients with Rheumatoid Arthritis. Türk Osteoporoz Dergisi, Cilt: 24 - Sayı: 2, 46–52. https://ajindex.com/articles/639698

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005;4:130-6
  2. Orstavik RE, Haugeberg G, Mowinckel P, Høiseth A, Uhlig T, Falch JA, et al. Vertebral deformities in rheumatoid arthritis:a comparison with population-based controls. Arch Intern Med 2004;164:420-5
  3. Forsblad D’Elia H, Larsen A, Waltbrand E, Kvist G, Mellström D, Saxne T, et al. Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis 2003;62:617-23
  4. Sinigaglia L, Varenna M, Girasole G, Bianchi G. Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin N Am 2006;32:631-58
  5. Abdel Meguid MH, Hamad YH, Swilam RS, Barakat MS. Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and structural bone damage. Rheumatol Int 2013;33:697-703
  6. Caetano-Lopes J, Rodrigues A, Lopes A, Vale AC, Pitts-Kiefer MA, Vidal B, et al. Rheumatoid Arthritis Bone Fragility Is Associated With Upregulation of IL17 and DKK1 Gene Expression. Clin Rev Allergy Immunol 2014;47:38-45
  7. Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T,et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007;204:41-7
  8. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003;14:155-74
  9. Witowski J, Ksiazek K, Jorres A. Interleukin-17: a mediator of inflammatory responses. Cell Mol Life Sci 2004;61:567-79
  10. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009;27:485-517
  11. Lee Y. The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases. BMB Rep 2013;46:479-83
  12. Kuestner RE, Taft DW, Haran A, Brandt CS, Brender T, Lum K, et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol 2007;79:5462-73
  13. Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, Derry J, et al. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 2006;177:36-9
  14. Li X, Yuan FL, Lu WG, Zhao YQ, Li CW, Li JP, et al. The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis. Biochem Biophys Res Commun 2010;397:131-5
  15. Hwang SY, Kim HY. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells 2005;19:180-4. 1